🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are permanent bilateral carotid filters useful for preventing stroke in high risk AF patients? Promising results presented by ⁦Ashkan Shoamanesh⁩ at #ESOC2025 Phase III trial is planned ⁦European Stroke Org⁩

First RCT of colchicine in acute intracerebral hemorrhage (ICH) at #ESOC2025 shows it's feasible & potentially safe. Though not powered for efficacy, no ischemic strokes occurred, and recurrent ICH only in placebo group. Phase III coming next! #ESOC2025 #Stroke #VoiceOfStroke

A great honor to present CoVasc-ICH at the #ESOC2025, establishing the feasibility of testing colchicine in acute ICH. The efficacy and safety of colchicine will be formally tested in the upcoming CoVasc-ICH 2. Ashkan Shoamanesh European Stroke Org PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine

Kudos to Aristeidis Katsanos for his effective leadership of CoVasc-ICH! This Canada-led first RCT testing colchicine in acute ICH has provided the requisite feasibility metrics to effectively plan our global phase III trial, CoVasc-ICH 2 (phri.ca/research/covas…). Stay tuned!

In the race to find life-saving treatments during COVID, Canada was left behind—while the UK sprinted ahead with a model we can learn from. Learn more in #TheFutureOfHealth by Roche Canada, with Dr. PJ Devereaux (@PHRIResearch) and Barbara Zrinscak of Roche.

Please join us for #McMaster Cardiology regional #GrandRounds Tuesday, May 27, 2025 8 am EST Delighted to welcome Dr Raed Joundi to share insights into the #heart-#brain connection #CognitiveFunction McMaster Stroke Program

📢 We're #hiring! Join the #PHRI team in our Quality Assurance Department. We’re looking for: 🔹 Quality Assurance Coordinator 🔹 Junior Quality Assurance Coordinator Apply by June 4! 🔗phri.ca/careers/ #HealthResearch #QAJobs #ClinicalResearch #PHRIResearch #Job

Join us at next week’s #Cardiology Regional Grand Rounds, where PHRI Investigator Natalia McInnes will present “Remission of Type 2 #Diabetes Following Surgical and Medical Interventions.” Harriette Van Spall, MD MPH 🇨🇦 McMaster Health Sciences McMaster Heart Function Education McMaster University Department of Medicine #CardioTwitter #HealthResearch

#STROKE: Substudy of ANNEXA-I shows that in patients with apixaban- or rivaroxaban-associated ICH, andexanet compared with usual care produced greater reduction in anti-FXa and greater increase in ETP at 1 hour. #AHAJournals ahajrnls.org/455C32G

In this📑we 💥map 🌎regions over/underrepresented in pivotal HF #RCTs relative to Dz 💥show that regional disparities in participant #enrolment are related to regional #disparities in site recruitm’t Estimating Site #RepresentationIndex pre trial can help doi.org/10.1002/ejhf.3…

Does targeting higher vs lower #BP during non-cardiac surgery affect cognition in older adults? A large int'l sub-study of POISE-3 led by #PHRI scientist Maura Marcucci says: no significant difference in #delirium or cognitive decline 1 year post-op. phri.ca/cogpoise-3/

Jeff Healey presenting the first Stuart Connolly Annual Lecture at ⁦SIAC⁩ meeting in Cartagena! Thank you ⁦PHRI.ca Population Health Research Institute 🇨🇦⁩ for supporting this initiative! ⁦CCS⁩ ⁦William F McIntyre⁩ ⁦Eugene Crystal MD FRCPC⁩ ⁦Linda Johnson⁩

🧬 1era Conferencia Stuart Connolly SIAC By: Dr Jeffrey Healey 🫀PHRI.ca Population Health Research Institute 🇨🇦 “It is about the achievements, it is about the science, but, at the end of the day, it is about the people”. 🔥 #siac2025

#ERA25 Late-Breaking session day 2 Now Michael Walsh, from Hamilton, Canada. “Spironolactone in patients undergoing maintenance dialysis: the ACHIEVE trial”. Background, reasons for trial… Active drug run-in for 60 days (excluded if K was 5.8 or higher, then blind RCT with 25

#ERA2025 "Götterdämmerung" in Vienna No Benefit for spironolactone in dialysis pat by @lastwalsh ACHIEVE comfirms ALCHEMIST

#PHRI Senior Scientist Michael Walsh presented results from the large international #ACHIEVE trial today. 👏 Kudos to Michael and the entire study team for this impactful work! Learn more about ACHIEVE: phri.ca/research/achie… #PHRIResearch #ERA2025 McMaster Health Sciences McMaster University Department of Medicine

Pleasure to collaborate cardio-met once again! Check out the first post of our new #CME #tweetorial series on optimal secondary prevention of non-cardioembolic ischemic #stroke or high-risk #TIA! PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine McMaster Stroke Program McMaster Health Sciences #MedEd #neurotwitter

Today was a day of special joy for me. Congratulations Tauben Averbuch MD! Am so happy to have journeyed w you over the last 8 yrs. Posting photos of your 1st poster yrs ago -> your LBCT present’n at #HFA🥺 Proud of many things, but especially your integrity, work ethic, & respect for all

We’re excited to announce the first-ever #PHRI Career Award recipients!🎉 Congratulations to Emilie Belley-Côté, Flavia Borges, David Conen, William McIntyre, Jessica Spence, Harriette Van Spall, & Mike Walsh! Read more about the award: phri.ca/careerawards25/ #ResearchExcellence